galderma articles ↓

Cetaphil has launched 2 new products that are targeted at oily or acne-prone skin. The products are called, take a breath; Cetaphil DermaControl Oil Control Moisturiser SPF 30 and Cetaphil DermaControl Oil Control Foam Wash. The Oil Control Moisturizer is promoted as a lightweight 3-in-1 moisturizer for acne-prone skin. It is said to provide broad spectrum sun protection, control shine without over-drying. The …

In a series of 6 videos, Cynthia Nixon who played Miranda in Sex and The City, talks about her battle with rosacea. The professionally produced videos point viewers to the …

How much does Galderma earn each year from Oracea sales ? Well the actual amount is not published, but in September 2011 court proceedings we learnt that Mylan Pharmaceuticals projected sales of $260m in 2011 for Oracea. The parent company of Galderma, L’Oreal does not publish Oracea sales figures, so this press release is as close as you can find to something that …

The mysterious CD5024 1% Cream for which Galderma is conducting a large Phase III trial, has further been confirmed as the anti-parasitic Ivermectin.

This latest confirmation comes from the World Heath Organisation’s International Clinical Trials Registry Platform Search Portal. The search for CD5024 reveals trials that have completed in the Czech Republic, Germany and Hungary. The register was created in 2006, the same year as when …

Some Phase II Trial results for Sansrosa were presented at the recent 2012 AAD Annual Meeting in San Diego. Joseph F. Fowler, M.D., Clinical Professor of Dermatology at the University of Louisville was the principal study investigator. A summary of these results was mentioned in October 2011 via a press release covered here: Sansrosa not Susceptible to Tolerance or Rebound Whilst …